Perspective Therapeutics
CATX
27 hedge funds and large institutions have $5.63M invested in Perspective Therapeutics in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
4% more funds holding
Funds holding: 26 → 27 (+1)
0.01% less ownership
Funds ownership: 0.62% → 0.61% (-0.01%)
46% less capital invested
Capital invested by funds: $10.5M → $5.63M (-$4.85M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$810K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$341K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$124K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$120K |
| 5 |
Goldman Sachs
New York
|
+$101K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$1.87M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$197K |
| 3 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$58.2K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$33K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$5.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JFA
26
JNBA Financial Advisors
Bloomington,
Minnesota
| $8K | – | – | – |
|
27
Nomura Holdings
Tokyo,
Japan
| $5K | +$7.18K | +290 | New |
|
|
MHP
28
Manatuck Hill Partners
Westport,
Connecticut
| – | -$1.87M | -60,000 | Closed |
|
|
29
Citadel Advisors
Miami,
Florida
| – | -$197K | -6,309 | Closed |
|
|
30
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$33K | -1,065 | Closed |
|
|
31
BNP Paribas Financial Markets
Paris,
France
| – | -$5.2K | -167 | Closed |
|
CATX Hedge Fund Activity: Q3 2014 in Review
27 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2014, worth a combined $5.63M — down 46% from $10.5M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CATX positions and 4 closed out — a net gain of 1 holder — while 8 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $810K. The largest seller was Manatuck Hill Partners, exiting entirely with an estimated $1.87M sold.
- 27 institutional investors held Perspective Therapeutics (CATX) as of Q3 2014, up from 26 in Q2 2014.
- Funds reported $5.63M of Perspective Therapeutics stock for Q3 2014, down 46% quarter-over-quarter.
- 5 funds opened new Perspective Therapeutics positions in Q3 2014 and 4 closed out, a net change of +1 holder.
- The largest Perspective Therapeutics buyer in Q3 2014 was Vanguard Group, an estimated $810K added.
- The largest Perspective Therapeutics seller in Q3 2014 was Manatuck Hill Partners, an estimated $1.87M sold.
Based on aggregated 13F filings for Q3 2014.